3 ms·
> If you start a pharmaceutical startup anywhere on earth, your business model is "sell to America". There is no other market. what should these 'corporations'
by apwell23 1y ago
> If you start a pharmaceutical startup anywhere on earth, your business model is "sell to America". There is no other market.
what should these 'corporations' do instead?
- ceejayoz 1y agoYes, startups tend to be corporations. And really, the model is "sell the startup to American corporations, who then milk Americans". Pfizer bought BioNTech's (Turkish/German) mRNA tech, for example. Insulin's price skyrocketed, despite being a hundred years old. It didn't get harder to make, distribute, sell. They just wanted more. Or Shkreli's purchase of Daraprim (https://www.bbc.com/news/business-34917918 https://www.bbc.com/news/business-34917918), a ~70 year old drug. They hiked the price from $13.50/pill to $750/pill. Did it get 55x harder to make suddenly? Of course not. It still costs $1/pill to make.
- apwell23 1y ago> And really, the model is Thats not the model. You've made this about something completely different that i am not particularly interested in discussing atm. later.